Tenet Healthcare (THC) Tops Q1 EPS by 12c; Provides Q2, FY16 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Mizuho Securities Downgrades Tenet Healthcare (THC) to Neutral
May 4, 2016 7:23 AM EDTMizuho Securities downgraded Tenet Healthcare (NYSE: THC) from Outperform to Neutral with a price target of $33.00.
Analyst Sheryl Skolnick commented, "While we applaud the transformation of THC from an inpatient focused, singlenote play to a better-positioned, more diversified health care provider, we... More
